Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
At-risk healthcare workers being vaccinated against Ebola in Uganda

At-risk healthcare workers being vaccinated against Ebola in Uganda

Healthcare workers in Uganda have begun vaccinating high risk health workers against the deadly viral infection Ebola this week. This is the first time that a vaccination drive has begun before the actual outbreak.

This precaution is being taken because the health care officials are worried that the infection would spread into the country from the borders shared with Democratic Republic of Congo. At present the outbreak in Democratic Republic of Congo is at its worst. The fear of transmission of the infection via the borders is heightened by the armed conflicts in the region, say officials.

Ebola virus attacks the immune system illustration: Image Credit: Crevis / Shutterstock

Ebola virus attacks the immune system illustration: Image Credit: Crevis / Shutterstock

In DRC till date, this season, around 300 cases of Ebola have been suspected with 265 confirmed cases of the disease. The World Health Organization (WHO) report says that till date the infection has killed 151 individuals in the country. In a statement the WHO states, “In vaccinating frontline health workers against Ebola virus disease even before Uganda detects a single case, health authorities are being cautious having learnt bitter lessons from previous outbreaks.”

The vaccine that is being administered is still experimental but has been shown to be protective in the clinical trials. It will be administered only to around 2000 first contact health care workers who are working near the borders of DRC in the north Kivu province says the WHO and would not be available for the general public.

“It is highly likely that Uganda may import Ebola virus disease from DRC given the closeness of the current epicenter, the high population movements due to trade, social-cultural connections and easy accessibility of health services in Uganda,” the WHO said. The individuals in DRC who have been in contact with an Ebola patient have been vaccinated and those in contact with these contacts have also been vaccinated. This is called the “ring vaccination strategy” and is an effective method of eradicating highly contagious infectious diseases, say the officials.

Yonas Tegegn Woldemariam, WHO’s Uganda representative said, “In previous [Ebola] outbreaks, Uganda lost health workers, including the renowned Dr Matthew Lukwiya, as they cared for patients. Scientists believe such invaluable lives would have been saved had a vaccine been in existence then.”

Jane Aceng, Uganda’s health minister in a statement added, “The public health risk of cross border transmission of Ebola to Uganda [from DRC] was assessed to be very high at the national level. The affected areas in the DRC [North Kivu and Ituri provinces] are about 100km from Uganda’s border districts. An undiagnosed Ebola patient could present to a health facility in Uganda for medical attention. This context puts the healthcare and frontline workers in Uganda at risk of being in contact with an [Ebola] case.”

Ebola is a deadly viral infection that was first detected and identified in 1976. Since then there have been regular outbreaks across Central and West African countries. Uganda was affected before in 2000 and 2001 where the infection killed 261 and infected 574 individuals. The infection killed 11,000 died in Sierra Leone, Liberia and Guinea and infected 28,000 in the period between 2014 and 2016.

The infection is capable of killing 20 to 70 percent of those who are infected depending on the strain of virus. Once infected only management available is supportive therapy. There are some experimental antibody based therapies that are being tried in treating the disease. Some of these combinations include ZMapp, REGN-EB3, the antiviral drug remdesivir and single-antibody drug called mAb114.

This latest vaccine to be administered has been developed by Merck and is not yet licensed.

Tagged with:

About author

Related Articles